CAR T-cell therapy (Inceptor Bio)

N/A

Report date: 2025/03/14 16:43:12

Base Information

Drug NameCAR T-cell therapy (Inceptor Bio)

Drug Alias NameCAR-T (Inceptor Bio)

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapyBiologics > Protein drugs > Recombinant protein > Fusion protein

Mechanisms of ActionCD70 antigen modulators

TargetsCD70 antigen

Therapy Area/IndicationsSolid tumoursCarcinoma, Renal CellNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesInceptor Bio LLC

China Registration ClassN/A

Develop Information

Active CompaniesInceptor Bio LLC

Inactive CompaniesN/A

Active IndicationsSolid tumoursCarcinoma, Renal Cell

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A